|
Market Closed -
Nasdaq
00:00:00 29/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 27.39 USD | +4.82% |
|
+11.89% | +2.28% |
| 08-18 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 08-07 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
| Market Cap | 1.17B 1.02B 969M 879M 1.65B 112B 1.66B 11.6B 4.48B 57.07B 4.37B 4.28B 183B | P/E 2026 * |
12.6x | P/E 2027 * | 10.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.47B 1.29B 1.22B 1.11B 2.08B 141B 2.09B 14.62B 5.65B 71.93B 5.51B 5.39B 231B | EV / Sales 2026 * |
1.96x | EV / Sales 2027 * | 1.72x |
| Free-Float |
47.23% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMPH | Delayed | |
CBOE
| AMPH | Real-time | |
|
Boerse Muenchen
| 29A | Real-time | |
|
Tradegate
| 29A | Real-time | |
|
Börse Stuttgart
| 29A | Delayed | |
|
Deutsche Boerse AG
| 29A | Delayed |
Last Transcript: Amphastar Pharmaceuticals, Inc.
| 1 day | +4.82% | ||
| 1 week | +11.89% | ||
| Current month | +21.57% | ||
| 1 month | +24.44% | ||
| 3 months | +25.76% | ||
| 6 months | +44.08% | ||
| Current year | +2.28% |
| 1 week | 24.2 |  | 27.8 |
| 1 month | 21.52 | | 27.8 |
| Current year | 16.64 | | 29.52 |
| 1 year | 16.64 | | 29.52 |
| 3 years | 16.64 | | 65.92 |
| 5 years | 16.64 | | 67.66 |
| 10 years | 12.05 | | 67.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Feng Zhang
CEO | Chief Executive Officer | 79 | 29/02/1996 |
Zi Ping Luo
COO | Chief Operating Officer | 76 | 29/02/1996 |
William Peters
DFI | Director of Finance/CFO | 58 | 01/04/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Zi Ping Luo
CHM | Chairman | 76 | 29/02/1996 |
Yong Feng Zhang
BRD | Director/Board Member | 79 | 29/02/1996 |
William Peters
BRD | Director/Board Member | 58 | 04/08/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/09/26 | Sell | Chief Financial Officer | -4,139 | 0.0097% | ||
| 16/09/26 | Exercice | Chief Technology Officer | 30,000 | 0.0705% | ||
| 02/09/26 | Sell | Chief Technology Officer | -3,187 | 0.0075% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.82% | +11.89% | +2.01% | -42.09% | 1.11B | |
| +0.11% | +1.71% | +63.52% | +117.61% | 1,055B | |
| +0.27% | +0.92% | +51.33% | +73.35% | 654B | |
| +0.73% | +0.68% | +20.70% | +74.90% | 467B | |
| -1.36% | -2.58% | +40.20% | +42.33% | 348B | |
| +1.34% | +4.53% | +23.37% | +29.55% | 275B | |
| -0.48% | -0.54% | +13.56% | +13.50% | 258B | |
| +0.85% | +6.35% | +53.17% | +54.39% | 224B | |
| +0.85% | +1.10% | +35.78% | +101.82% | 187B | |
| -0.30% | -2.98% | -27.62% | -61.28% | 171B | |
| Average | +0.60% | +1.66% | +27.60% | +40.41% | 363.95B | |
| Weighted average by Cap. | -0.05% | +1.01% | +40.68% | +69.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 748M 658M 622M 564M 1.06B 71.78B 1.07B 7.45B 2.88B 36.63B 2.81B 2.75B 118B | 784M 690M 652M 592M 1.11B 75.3B 1.12B 7.81B 3.02B 38.42B 2.94B 2.88B 123B |
| Net income | 99.32M 87.35M 82.6M 74.92M 141M 9.53B 142M 989M 382M 4.86B 373M 365M 15.63B | 115M 102M 95.99M 87.07M 164M 11.08B 164M 1.15B 444M 5.65B 433M 424M 18.17B |
| Net Debt | 303M 267M 252M 229M 430M 29.13B 432M 3.02B 1.17B 14.86B 1.14B 1.11B 47.76B | 184M 162M 153M 139M 261M 17.68B 262M 1.83B 708M 9.02B 691M 676M 28.98B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/09/26 | $27.39 | +4.82% | 751,800 |
| 25/09/26 | $26.13 | -0.53% | 376,921 |
| 24/09/26 | $26.27 | +5.25% | 572,080 |
| 23/09/26 | $24.96 | +2.63% | 508,095 |
| 22/09/26 | $24.32 | -0.65% | 522,394 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMPH Stock
Select your edition
All financial news and data tailored to specific country editions
